Diana Pankevich, Ph.D., is the policy lead at Pfizer for clinical trials, patient centricity, and preapproval access. Previously Diana worked at the White House for President Obama’s Council of Advisors on Science and Technology. She holds a Ph.D. from Boston University and completed postdoctoral training at the University of Pennsylvania.